22.07.2024|Achievements
Top Biomaterials Processing Company in Europe 2024
We have been ranked among the ‘Top Biomaterials Processing Company in Europe 2024’ according to Life Sciences Review.
In recent years, a significant increase in research efforts targeting bone regeneration has resulted in promising solutions. Medical Inventi is at the forefront of biomedical innovation, embodying an unusual blend of academic brilliance and entrepreneurial vision.
‘FlexiOss® is one of the few products that does not contain animal by-products and can be used to treat all patients, regardless of their religious beliefs,’ says Adrian Maciejewski, M.D., Clinical Development Manager, on Life Sciences Review.
Our motivation is to constantly strive for excellence and to innovate even more. In turn, our goal is to develop and deliver solutions that will advance scientific knowledge and significantly impact the lives of patients worldwide.
‘Medical Inventi is currently developing a new product consisting of three compounds that are further separated into two phases to support bone and cartilage regeneration. The product has been tested on animals and has produced very promising results, indicating its potential efficacy and reliability.’ – confirms CEO Maciej Maniecki.